Nightingale Health Oy Revenue and Competitors

Claim your profile

Helsinki, Finland

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nightingale Health Oy's estimated annual revenue is currently $18.9M per year.(i)
  • Nightingale Health Oy's estimated revenue per employee is $155,000

Employee Data

  • Nightingale Health Oy has 122 Employees.(i)
  • Nightingale Health Oy grew their employee count by 44% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$25.6M165-17%N/AN/A
#2
$18.9M12244%N/AN/A
#3
$20.8M13431%N/AN/A

Nightingale Health Ltd. is a pioneering Finnish biotech company, transforming healthcare and research through use of its innovative blood analysis service. By providing comprehensive and cost-effective data on blood, Nightingale's mission is to solve the world's number one health problem - chronic diseases. At the heart of its technology is a combination of NMR-based analysis and proprietary software that generates data used by researchers and clinicians to improve risk prediction of diseases, such as diabetes and cardiovascular diseases. There are currently over 100 scientific publications that have successfully applied Nightingale's method, including major metabolomics and epidemiological studies. Nightingale is built on an unrivalled scientific foundation, comprising of an interdisciplinary team of experts in computational medicine, healthcare IT and business. With headquarters and laboratory facilities in Finland (along with two franchising laboratories in the UK), Nightingale routinely provide services for academic research and industrial R&D customers internationally. The next major milestone for the company will be bringing its blood analysis platform to global healthcare providers. Nightingale is a member of one the world's biggest health-focused start-up accelerators StartUp Health. Chosen as an Official Solver by MIT's Solver program.

keywords:N/A

N/A

Total Funding

122

Number of Employees

$18.9M

Revenue (est)

44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nightingale Health Oy News

2022-04-19 - Serum metabolomic profiles associated with subclinical and ...

Ethical permission was granted by the Lothian Medical Research Ethics ... nuclear magnetic resonance (NMR) platform (Nightingale, Helsinki,...

2021-11-02 - Tuukka Paavola appointed as Chief Financial Officer of Nightingale Health Plc

Tuukka Paavola appointed as Chief Financial Officer of Nightingale Health Plc Tue, Nov 02, 2021 08:00 CET Company release 2 November 2021 at 9:00 a.m. (EET) Nightingale Health Plc (”Nightingale”) has appointed Tuukka Paavola as Chief Financial Officer. Paavola will join Nightingale’s manageme ...

2021-10-29 - Conversion of Nightingale Health Plc’s Series A shares and EMP shares to Series B shares

Conversion of Nightingale Health Plc’s Series A shares and EMP shares to Series B shares Fri, Oct 29, 2021 14:00 CET Company release 29 October 2021 at 3:00 p.m. (EEST) The Board of Directors of Nightingale Health Plc has in its meeting on September 30, 2021 and October 7, 2021, approved requ ...

2021-10-28 - Nightingale and BioBank Japan to realise personalised medicine and preventative health in Japan

Nightingale and BioBank Japan to realise personalised medicine and preventative health in Japan Thu, Oct 28, 2021 08:00 CET Press release 28 October 2021 at 9:00 (EEST) Nightingale Health Plc’s Japanese subsidiary Nightingale Health Japan KK (together ”Nightingale”) announces a long-term coll ...

2019-08-12 - Form N-PX Eaton Vance Tax-Managed For: Jun 30

... OF AUDITOR: PRICEWATERHOUSECOOPERS Mgmt For For OY HAS ..... Mgmt For For DIRECTOR 9 TO RE-ELECT MR ANTHONY NIGHTINGALE AS ...... Shareowner proposal on sugar and public Shr Against For health ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$40.3M122-5%N/A
#2
$27.7M12282%N/A
#3
$28.6M12650%N/A
#4
$21.8M12819%N/A
#5
$26.1M129659%N/A